Loading
Yunkang Group Ltd. Stock: price and insider trades · Hong Kong
Yunkang Group Ltd.: what insiders have been doing
This page follows insider dealings at Yunkang Group Ltd. as filed with HKEX, a company from the Health Care sector. In the past year (19 October 2025 to 19 October 2026), 14 filings came from 1 insider.
There is no open-market purchase to report; the filings show 14 sales worth €799k by 1 insider. At €167k, the sale published on 6 November 2025 by ZHANG Yong is the largest of the period.
Half of the filings or more reach the HKEX feed on the day of the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 14 filings, this issuer sits above that mark. Since 2022, the database holds no purchases and 18 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Vivos Inc and Anixa Biosciences Inc. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
23
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€3M
18 ops. · all time
Who traded when
BuySaleZHANG Yong18 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,462 of 26,289 companies
46.2
score / 100
Value60
Quality32
FCF yld73%
Earn yld0.9%
EV/EBITDA12.1x
ROE5.4%
Gross mgn30%
Net mgn0.5%
Debt/EBITDA8.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$0.59
Analyst consensus
1 analystsHK$10.88Target HK$10.88(+1760%)HK$10.88
Income statement
RevenueHK$601.4M
Gross profitHK$182.8M30% margin
EBITDAHK$85.1M14% margin
Net incomeHK$2.9M11.2% margin
Valuation
PER (trailing)5.3x
P/Book0.3x
Beta-0.72
Balance sheet & cash
Market capHK$342.4M
Total debtHK$692.3M
Free Cash FlowHK$246.2M
Debt / Equity59%
Profitability & ownership
ROE5.4%
ROA2.4%
% insiders76.5%
% institutions0.0%
Last declaration on 28 August 2026
Declarations23 total
231,000 shares@ HK$0.600.051% mcap48.6% of flowShareXHKGHKEX:DA20260827E00396
165,000 shares@ HK$0.590.036% mcap34.5% of flowShareXHKGHKEX:DA20260813E00421
81,000 shares@ HK$0.590.018% mcap16.9% of flowShareXHKGHKEX:DA20260806E00428
498,000 shares@ HK$1.010.14% mcap100.0% of flowShareXHKGHKEX:DA20260319E00453
210,000 shares@ HK$1.0221.4% of flowShareXHKGHKEX:DA20260313E00075
357,000 shares@ HK$0.971.4% of flowShareXHKGHKEX:DA20260115E00433
498,000 shares@ HK$1.001.9% of flowShareXHKGHKEX:DA20260108E00624
695,000 shares@ HK$0.982.6% of flowShareXHKGHKEX:DA20251225E00024
810,000 shares@ HK$1.003.2% of flowShareXHKGHKEX:DA20251211E00495
55,000 shares@ HK$1.020.2% of flowShareXHKGHKEX:DA20251204E00395
385,500 shares@ HK$1.041.6% of flowShareXHKGHKEX:DA20251120E00445
1,465,500 shares@ HK$1.025.9% of flowShareXHKGHKEX:DA20251106E00351
749,000 shares@ HK$1.023.0% of flowShareXHKGHKEX:DA20251030E00504
1,070,000 shares@ HK$1.094.6% of flowShareXHKGHKEX:DA20251024E00600
8,539,500 shares@ HK$1.3846.0% of flowShareXHKGHKEX:DA20251017E00522
755,000 shares@ HK$1.323.9% of flowShareXHKGHKEX:DA20251010E00690
1,154,000 shares@ HK$1.275.7% of flowShareXHKGHKEX:DA20251003E00505
2,618,000 shares@ HK$1.5716.0% of flowShareXHKGHKEX:DA20250924E00397
1,200,000 sharesShareXHKGHKEX:DA20250716E00446
4,800,000 sharesShareXHKGHKEX:DA20250313E00356
20,000,000 sharesShareXHKGHKEX:DA20241030E00189
181,108,000 sharesShareXHKGHKEX:DA20221123E00400
250,108,000 sharesShareXHKGHKEX:DA20220601E00202
23 of 23 declarations
About Yunkang Group Ltd.
Yunkang Group Ltd. is a company operating in the health and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange (XHKG).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
